Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SHE:301093)
China · Delayed Price · Currency is CNY 84.35
+9.57 (12.80%)
At close: Jan 23, 2026
SHE:301093 Market Cap
SHE:301093 has a market cap or net worth of 13.6 billion as of January 23, 2026. Its market cap has increased by 377.09% in one year.
Market Cap
13.60B
Enterprise Value
12.46B
Revenue
604.86M
Ranking
n/a
PE Ratio
273.09
Stock Price
84.35
Market Cap Chart
Since November 1, 2021, SHE:301093's market cap has increased from 7.03B to 13.60B, an increase of 93.39%. That is a compound annual growth rate of 16.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 13.60B | 65.07% |
| Dec 31, 2025 | 8.24B | 178.70% |
| Dec 31, 2024 | 2.96B | -32.51% |
| Dec 29, 2023 | 4.38B | 28.05% |
| Dec 30, 2022 | 3.42B | -51.34% |
| Dec 31, 2021 | 7.03B | -0.04% |
| Nov 1, 2021 | 7.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhende Medical | 18.85B |
| Shenyang Xingqi Pharmaceutical | 18.37B |
| Andon Health | 17.79B |
| Micro-Tech (Nanjing) Co.,Ltd | 15.98B |
| Autek China | 14.77B |
| Tofflon Science and Technology Group | 13.55B |
| Eyebright Medical Technology (Beijing) | 12.20B |
| Sansure Biotech | 11.58B |